Rocket


Overview
Financials
News + Filings
Key Docs
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Praxis Precision Medicines, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
12/01/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Praxis Precision Medicines Announces CFO Transition CAMBRIDGE, Mass., Dec. 01, 2020 - Praxis Precision Medicines, Inc. , a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance, today announced that Stuart Chaffee, Ph.D., will be transitioning from his current position as the Company's chief financial officer to a part-time role as a strategic advisor to Praxis. The Company has commenced a search for a full-time chief financial officer. Lauren Mastrocola, the Company's vice president of finance and principal accounting officer, has assumed the responsibilities of principal financial officer on an interim basis. “I'm incredibly proud of what we've built at Praxis and co..."
11/17/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "Praxis Precision Medicines Provides Update On PRAX-114 IND Submission For The Treatment Of Major Depressive Disorder"
10/20/2020 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Amended and Restated Certificate of Incorporation of Praxis Precision Medicines, Inc",
"Amended and Restated Bylaws of Praxis Precision Medicines, Inc"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy